Skip to content

Clinical trials

Hemophilia B trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Country / region: Belgium Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20092
20101
20111
20121
20142
20182
20191
20201
20211
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Enrolling by invitation2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Bioverativ Therapeutics Inc.2
Novo Nordisk A/S2
Wyeth is now a wholly owned subsidiary of Pfizer2
ApcinteX Ltd1
Centre Hospitalier Universitaire de Liege1
Janssen Research & Development, LLC1
PedNet Haemophilia Research Foundation1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B19
Hemophilia A11
Joint Diseases2
Adrenal Hyperplasia, Congenital1
Adrenoleukodystrophy1
Andersen Syndrome1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Argininosuccinic Aciduria1
Aspartylglucosaminuria1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.